Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rufloxacin Derivative. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114276369B details a novel synthesis of anti-tuberculosis indoloquinolines from rufloxacin, offering improved solubility and resistance profiles for pharmaceutical manufacturing.